Latest / Bloomberg Law / Mueller Accused Manafort of Tampering with Witnesses
Transcript
- 0:03Speaker 1: Welcome to the Bloomberg Law Podcast. I'm June Grosso. Every
- 0:07Speaker 1: day we bring you insight and analysis into the most
- 0:10Speaker 1: important legal news of the day. You can find more
- 0:13Speaker 1: episodes of the Bloomberg Law Podcast on Apple Podcasts, SoundCloud
- 0:18Speaker 1: and on Bloomberg dot com slash Podcasts. President Trump and
- 0:22Speaker 1: his attorney Rudy Giuliani claimed that the president can pardon himself,
- 0:26Speaker 1: but Giuliani says Trump is still willing to be interviewed
- 0:29Speaker 1: in the Special Counsel's Rushia investigation. He spoke on CNN's
- 0:33Speaker 1: Cuomo Prime Time. President Trump wants to be interviewed. I
- 0:38Speaker 1: hope that's true, believes he is innocent. He says to me,
- 0:41Speaker 1: I didn't do anything wrong. I hope we didn't do
- 0:43Speaker 1: anything wrong. But the world isn't that simple. Justice system
- 0:47Speaker 1: isn't as fair as you think. Joining me is Brad Moss,
- 0:51Speaker 1: a partner Mark Sade. Brad Trump has started yet another
- 0:54Speaker 1: legal controversy over whether a president can pardon himself. In
- 0:58Speaker 1: a legal opinion that was issue four days before President
- 1:01Speaker 1: Richard Nixon stepped down, the Justice Department's Office of Legal
- 1:05Speaker 1: Counsel concluded the president can't pardon himself although other legal
- 1:09Speaker 1: experts say he can. What's your opinion. I stand by
- 1:14Speaker 1: the d j's view that the president can't pardon himself.
- 1:17Speaker 1: The concept that any one person can be both judge, jury,
- 1:21Speaker 1: and quote unquote executioners just an ethemounts or entire system
- 1:26Speaker 1: of government and our entire criminal justice system. So the
- 1:29Speaker 1: more the mere concept that the president could somehow commit
- 1:33Speaker 1: a crime and then pardon himself that all himself to
- 1:35Speaker 1: keep going on just doesn't stand with our constitutional republic.
- 1:38Speaker 1: And the only reason we're talking about this, you know,
- 1:41Speaker 1: I know the president likes to complain that we all
- 1:43Speaker 1: we all focused on the Russia prope The only reason
- 1:45Speaker 1: we're talking about this is because the president is circuits
- 1:47Speaker 1: keep mouthing off on television with really dangerous and unnecessary
- 1:52Speaker 1: self force and unforced errors, and this is just another
- 1:55Speaker 1: one of them. Past presidents Richard Nixon and Bill Clinton
- 1:59Speaker 1: did not, according to reports, even consider having you know,
- 2:04Speaker 1: pardnering themselves. Is Trump laying the groundwork to push the
- 2:08Speaker 1: limits of presidential power or is this a negotiation strategy. Oh,
- 2:13Speaker 1: it's a It's a good question, and it might be
- 2:15Speaker 1: a little bit of ultimate. Look, Donald Trump has a
- 2:17Speaker 1: very broad view of executive authority. He tends to take
- 2:22Speaker 1: the position that the article to authority granted him by
- 2:25Speaker 1: the Constitution is as powerful and plenary as he can
- 2:28Speaker 1: make it. And that's just his style of leadership anyways.
- 2:32Speaker 1: So the idea that he might take the view that
- 2:35Speaker 1: the d j's analysis was wrong and he could pardon himself,
- 2:38Speaker 1: I can't view that as are their own possibilities. But
- 2:40Speaker 1: in the end, yeah, and he's the ultimate salesman, the
- 2:43Speaker 1: ultimate negotiator. This is likely just part of his tactic
- 2:46Speaker 1: in terms of how he's negotiating with Muller and ultimately
- 2:50Speaker 1: with possible impeachment individuals later on. So that's I think
- 2:54Speaker 1: where this is really leading to some headlines now, and
- 2:58Speaker 1: that is that we know that that in Trump is
- 3:00Speaker 1: going to the G seven and he is expected to
- 3:03Speaker 1: meet with the Prime Minister of Canada Trudeau there Again,
- 3:07Speaker 1: Trudeau says that he expects that he will meet with
- 3:09Speaker 1: Trump at the G seven. Turning now to the trial
- 3:13Speaker 1: of former Trump campaign chairman Paul Manafort, the special counsel
- 3:17Speaker 1: has accused him of attempting to tamper with witnesses. Tell
- 3:20Speaker 1: us more about the accusations here. Yes, So, what the
- 3:25Speaker 1: government's motion laid out in the Africa from the relevant
- 3:28Speaker 1: agency official is that shortly after being indicted for the
- 3:32Speaker 1: second time, Mr Manafort reached out to certain individuals who
- 3:36Speaker 1: were part of his lobbying campaign in Europe about sex
- 3:40Speaker 1: seven years ago, and he tried to start coordinating and
- 3:43Speaker 1: sinking up testimony. Now that on in IT zone isn't
- 3:46Speaker 1: an issue, but the prom became that he tried to
- 3:50Speaker 1: start hinting at a certain line of testimony that the
- 3:53Speaker 1: people he was discussing this with new to be false,
- 3:56Speaker 1: and those individuals appear to have read it him out
- 3:58Speaker 1: and provided these communications to the government, and the government
- 4:03Speaker 1: has viewed that as an attempt to subbort and perjury
- 4:05Speaker 1: attempt to force a coerce false testimony from these individuals
- 4:10Speaker 1: who would be providing relevant testimony. In the end, this
- 4:12Speaker 1: is a very serious charge. He could almost's almost likely.
- 4:16Speaker 1: So it's almost certain that he's going to have his
- 4:18Speaker 1: bail revoked and wind up in prison until at least
- 4:21Speaker 1: his trial in September and July. Really it's almost certain
- 4:24Speaker 1: because that's going to be there's the June has been
- 4:27Speaker 1: set by the judge as the hearing date and you
- 4:29Speaker 1: think that it that he'll have his his bail revoked,
- 4:32Speaker 1: which he has fought hard for. Correct I mean, I personally,
- 4:36Speaker 1: if the allegations are viewed as persuasive by the judge,
- 4:40Speaker 1: I can't envision an alternative scenario of home confinement that
- 4:45Speaker 1: would eliminate the risk of him trying this again, because
- 4:48Speaker 1: not just that he himself did it, he went through intermediaries.
- 4:51Speaker 1: I mean, you have to cut him off from any
- 4:53Speaker 1: communication device ever, as well as anyone else in his house.
- 4:57Speaker 1: He had to take away all devices from his from
- 4:59Speaker 1: his wife, from his kid, any grandkids, anybody, you know,
- 5:01Speaker 1: it would be just ridiculous at that point. I mean,
- 5:04Speaker 1: I don't think that's really an option he'd want to
- 5:06Speaker 1: take any at that point. Anyways. I think at that
- 5:09Speaker 1: point it just becomes confinement in prison for as long
- 5:12Speaker 1: as it takes to get the trial. Would this have
- 5:16Speaker 1: been discovered if there wasn't such a focus on manifort,
- 5:21Speaker 1: and there were weren't so many resources of the FBI
- 5:24Speaker 1: and the and the prosecutor devoted to this case, It's possible.
- 5:30Speaker 1: You never quite know, you know, with any if it
- 5:33Speaker 1: was it's just a garden variety case. If they would
- 5:35Speaker 1: have been able to have kept track of all this
- 5:37Speaker 1: and have had whatever, you know, various methods of data
- 5:42Speaker 1: collection that they're using through search Warrenson, why are tests
- 5:45Speaker 1: never has been authorized by the courts, obviously, the full
- 5:47Speaker 1: extent of which we don't know. We don't know if
- 5:49Speaker 1: the individuals would have come forward in a garden variety case.
- 5:52Speaker 1: But that's a that aside the fact that Paul Manafort
- 5:56Speaker 1: was reckless enough to even try this, given all the
- 5:59Speaker 1: focus he knows is on him, given that he already
- 6:02Speaker 1: knows that his emails have been searched, his records have
- 6:05Speaker 1: been searched, that there's wire taps that have already been authorized.
- 6:08Speaker 1: That was just plain stupid by any analysis. So being
- 6:14Speaker 1: in prison might give him a different outlook than he's had,
- 6:18Speaker 1: as he has fought off any attempts to you know,
- 6:21Speaker 1: to turn to make a plea deal, correct, I mean,
- 6:24Speaker 1: And that's the that's the thing, is I mean, Palm
- 6:26Speaker 1: Manaford has lived the high life since the eighties. He
- 6:30Speaker 1: has he has consulted and lobbied for presidents and for
- 6:34Speaker 1: premiers and any number of people overseas. He's lived with
- 6:38Speaker 1: a very you know, high salary, high that high, that words,
- 6:41Speaker 1: and the significant assets. If he finds himself now just
- 6:45Speaker 1: prisoner number x y Z in a federal penitentiary, that
- 6:50Speaker 1: might be a sobering moment for him, and that might
- 6:52Speaker 1: kind of be the straw that breaks the camel's back
- 6:54Speaker 1: here to make him consider a plea deal and to
- 6:57Speaker 1: cooperate with Mueller's team. So, Brad, what happens next? Just
- 7:02Speaker 1: about thirty seconds here, Yeah, the manaforts team has to
- 7:06Speaker 1: file a response by the end of this week. That's
- 7:07Speaker 1: gonna be hearing next week on this. The judge is
- 7:09Speaker 1: going to make a decision probably on probably that day
- 7:12Speaker 1: at the hearing on whether or not to revoke the bail. Well,
- 7:15Speaker 1: it's going to be very interesting to see what their
- 7:18Speaker 1: response is because the Special Counsel has so seems to
- 7:21Speaker 1: have so much documentation of this. I was always great
- 7:25Speaker 1: to have you on, Brad. That's Brad Moss. He's a
- 7:27Speaker 1: partner in the Hard State. Allergan has found an unusual
- 7:34Speaker 1: and perhaps sham way to avoid challenges to the patents
- 7:37Speaker 1: of a blockbuster drug. It's bought protection and American Indian
- 7:41Speaker 1: Tribe sovereign immunity. Rival drug companies are challenging Allergan's transfer
- 7:46Speaker 1: of its patents for the dry eye drug restaces to
- 7:49Speaker 1: the St. Regis Mohawk tribe and Monday at oral arguments,
- 7:52Speaker 1: judges at the top patent court in the country question
- 7:55Speaker 1: whether Allergan was trying to circumvent review by the Patent
- 7:59Speaker 1: and Trademark Office. Joining me a Shuba Ghost director of
- 8:02Speaker 1: the Syracuse Intellectual Property Law Institute, super I think we
- 8:06Speaker 1: need a little background here. Why does Alergan want to
- 8:09Speaker 1: avoid review by the Patent office preferring a trial? Thank
- 8:15Speaker 1: you for having me on. First of all, the main
- 8:17Speaker 1: issue here are new procedures within the Patent Office that
- 8:21Speaker 1: were introduced into a Love twenty eleven that allow somebody
- 8:25Speaker 1: to challenge a patent and question its validity. And these
- 8:30Speaker 1: procedures have really struck down a lot of patents in
- 8:33Speaker 1: the last h six or seven years, and so a
- 8:36Speaker 1: lot of patent donors have been wary about them and
- 8:39Speaker 1: prefer to take their chances in the court. So the
- 8:42Speaker 1: Joice Department lawyer called Allergan's tactics a shell game. Judge
- 8:46Speaker 1: Timothy Dyke asked if renting or buying the tribe's protection
- 8:50Speaker 1: is problematic. Does Allergan admit that the only reason it
- 8:54Speaker 1: made this deal was to circumvent the system. I mean,
- 8:58Speaker 1: all of those are a loaded terms. I mean trying
- 9:02Speaker 1: to be a little bit neutral here. Um. Tribal sovereign
- 9:06Speaker 1: immunity is something that does exist, and I think Allergan
- 9:10Speaker 1: found a way to make a deal with the tribes,
- 9:13Speaker 1: so that was beneficial to both sides. In other words,
- 9:16Speaker 1: the tribes could get the benefit of the patent and
- 9:19Speaker 1: Allergan could provide some additional protection for its patents that,
- 9:24Speaker 1: as far as we know now are permitted within the law.
- 9:26Speaker 1: I mean, though the rulings of the court might might
- 9:29Speaker 1: shift that depending on where they come out. So what
- 9:32Speaker 1: I what I mean is Allergant basically said it's legal
- 9:35Speaker 1: and we did it. But is there another reason besides
- 9:37Speaker 1: getting the tribal sovereign immunity that it would make this deal?
- 9:42Speaker 1: H That's what I mean. That's a good question. Um,
- 9:44Speaker 1: I mean I think it. I ultimately have to ask
- 9:46Speaker 1: the company. There might be some some advantages and striking
- 9:51Speaker 1: these deals and working with with with the tribes, but
- 9:55Speaker 1: most likely the main advantage that it's getting is the
- 9:59Speaker 1: sovereign immunity. So now Critics of this move say that
- 10:05Speaker 1: it can cause problems down the road. It could sort
- 10:09Speaker 1: of um infect the patent system. Explain what the problems
- 10:13Speaker 1: might be if this is affirmed allowed. Sure, Congress did
- 10:20Speaker 1: allow create a system inn to challenge the validity of patents.
- 10:25Speaker 1: I think there was a general concern that patents had
- 10:29Speaker 1: to be given more strict review. Even though the us
- 10:33Speaker 1: P t O does do a thorough review in deciding
- 10:36Speaker 1: whether to grant the patent, those procedures are often done
- 10:40Speaker 1: without the participation of other interested parties. And so what's
- 10:44Speaker 1: a stake in this case? Are these procedures that have
- 10:48Speaker 1: been established by Congress that have been you know, they're
- 10:51Speaker 1: they're controversial, but I think in general there's the benefits
- 10:55Speaker 1: have been positive to basically allow certain reviews of patents,
- 10:59Speaker 1: And so if this is affirmed, if this is allowed,
- 11:03Speaker 1: then uh, we might see more of these deals being made. Again,
- 11:08Speaker 1: there's a question how much of those are possible to
- 11:10Speaker 1: be made and when they're They're both downsides and upsides
- 11:13Speaker 1: to these types of deals. But it may be a
- 11:16Speaker 1: way to get around the kind of systems for reviewing
- 11:19Speaker 1: patents that Congress created. In other tribes have reached similar
- 11:24Speaker 1: agreements with tech company with um to avoid tech companies
- 11:30Speaker 1: patents like Apples and Microsoft. Will the court be considering
- 11:35Speaker 1: the possible effect to the whole patent system when it
- 11:37Speaker 1: considers this, Well, I hope so. I mean, I think
- 11:41Speaker 1: this is not just isolated deals. Uh. There are the
- 11:44Speaker 1: technical legal issues about whether all Alligant and the Mohawk
- 11:48Speaker 1: tribe are working within what the law allows. But there
- 11:51Speaker 1: definitely are some adverse consequences that the court should consider
- 11:55Speaker 1: and I think will consider. They already have been surfacing
- 11:58Speaker 1: in the our arguments as you were for two earlier,
- 12:01Speaker 1: So two of the judges at the US Federal Court
- 12:05Speaker 1: of Appeals the patents seem to be sort of on
- 12:10Speaker 1: the side of the those who are opposing the Allergant deal.
- 12:15Speaker 1: What did you see that stood out to you? Well,
- 12:19Speaker 1: I think a lot of these issues have been priculating
- 12:22Speaker 1: since the deal was was publicized, you know, last fall.
- 12:26Speaker 1: I think the main question is when has a tribe
- 12:30Speaker 1: waived the sovereign immunity and tribal immunity tends to be
- 12:34Speaker 1: a fairly um arcane and robust concept. It's it's fairly controversial,
- 12:40Speaker 1: especially as it arises with respect to criminal investigations and
- 12:45Speaker 1: the basically the sovereignty and the independence of the tribe
- 12:49Speaker 1: in reaching certain decisions. But in this particular context, I
- 12:54Speaker 1: think there there is a concern as to whether by
- 12:58Speaker 1: taking the economic advantage of the patent system, which the
- 13:02Speaker 1: tribes have by receiving money in exchange as part of
- 13:06Speaker 1: these deals, whether they have effectively waived their immunity. Uh.
- 13:10Speaker 1: In other words, they basically have entered the patent system,
- 13:13Speaker 1: and they can't they can choose, you know, what they
- 13:15Speaker 1: can have enforced against them. So it is a narrower
- 13:19Speaker 1: ruling possible here instead of going to the entire issue
- 13:22Speaker 1: of sovereign immunity. Is there it narrower? Is it possible
- 13:26Speaker 1: that the court will make a narrower decision. It's it's possible,
- 13:30Speaker 1: But I think, you know, sovereign immunity tends to be
- 13:33Speaker 1: an all or nothing uh venture, and so it's hard
- 13:38Speaker 1: to see how they could narrow it beyond just simply
- 13:41Speaker 1: finding that there has been a waiver under these circumstances.
- 13:45Speaker 1: I think I think courts generally have avoided a broad
- 13:49Speaker 1: ruling by just simply saying that since sovereign entity exists
- 13:53Speaker 1: in a market economy they've waived their immunity. It's been
- 13:57Speaker 1: a lot more specific than that. So I think the
- 14:00Speaker 1: final ruling, if the court does find against immunity, might
- 14:03Speaker 1: be based on the particularities of this of this deal.
- 14:07Speaker 1: So among the companies that have filed arguments against Allergant
- 14:10Speaker 1: or Microsoft and tech companies that include Google, Amazon, and Oracle,
- 14:18Speaker 1: explain what what their arguments were and what their concerns are. Well,
- 14:22Speaker 1: this is this is getting yet a little bit of
- 14:24Speaker 1: an ongoing debate in the patent system between pharma's, pharmaceutical
- 14:28Speaker 1: companies and software companies. You know, pharmaceutical companies typically have
- 14:33Speaker 1: tried to be very protective of their patents, and I've
- 14:36Speaker 1: been very very wary of of devices or mechanisms that
- 14:41Speaker 1: Congress may have created or the USPTO may have created
- 14:44Speaker 1: that puts patents under close scrutiny. And the software and
- 14:48Speaker 1: the I T sectors, however, in general or a bit
- 14:52Speaker 1: more wary of patents. Um there's a lot more discussion
- 14:57Speaker 1: in that in that industry about whether patents on software
- 15:01Speaker 1: and information technologies do more harm than good, and so
- 15:04Speaker 1: there would be in favor of of systems that would
- 15:08Speaker 1: give more scrutiny to patents and really be very skeptical
- 15:11Speaker 1: of of things like this where they try to avoid
- 15:14Speaker 1: the mechanism of the Congress is created. All right, thanks
- 15:17Speaker 1: so much. The Federal Circuit is expected to make a
- 15:21Speaker 1: pretty fast decision after hearing the arguments yesterday. That's Shuba Ghost,
- 15:25Speaker 1: director of the Syracuse Intellectual Property Law Institute. Thanks for
- 15:29Speaker 1: listening to the Bloomberg Law podcast. You can subscribe and
- 15:33Speaker 1: listen to the show on Apple Podcasts, SoundCloud, and on
- 15:36Speaker 1: Bloomberg dot com slash podcast. I'm June Brosso. This is
- 15:41Speaker 1: Bloomberg Ye.